Inflammatory Diseases Terminated Phase 3 Trials for Ketorolac (DB00465)

Also known as: Inflammatory Disease

IndicationStatusPhase
DBCOND0041144 (Inflammatory Diseases)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02266433Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity DisordersTreatment